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Abstract
Introduction: Hypokalaemia is an unrecognised complication of vancomycin therapy.
Case presentation: We present a 68-year-old female with an infected hindquarter amputation site
who had incurred severe hypokalaemia with recurrent episodes of cardiac arrest requiring
cardioversion shortly after commencing intravenous vancomycin therapy. The cause of hypokalaemic
cardiac arrest was thought to be due to administration of low dose furosemide, however, holding
potassium-wasting diuretics did not restore normal serum potassium concentrations. After an
extended period of conservative management with potassium supplementation, spironolactone
therapy and cautious serum electrolyte monitoring, cessation of vancomycin led to the complete
resolution of hypokalaemia.
Conclusion: Clinicians should be aware that vancomycin therapy, even in the presence of normal
renal function, may be a reversible cause of severe hypokalaemia.
Introduction
Severe hypokalaemia associated with antibiotic use is rare
and is a recognised complication of dicloxacillin and
aminoglycosides, especially in conjunction with renal or
hepatic insufficiency. However, there have been no
previous reports associating vancomycin use with pro-
found hypokalaemia.
Case presentation
A 77-year-old Caucasian female was admitted under the
orthopaedic team for rehabilitation 2 months following
a left sided hindquarter amputation. There was no
radiological evidence of metastatic disease. Her significant
past medical history included moderate degree hyperten-
sion and mild left ventricular failure with an ejection
fraction of 55%. Her medications included chronic use of
multiple anti-hypertensives including ramipril, atenolol
and bendroflumethiazide, along with high dose opioids
for pain control. She had previously been on multiple
courses of 40 mg oral furosemide for peripheral oedema.
Due to prolonged non-healing of her amputation site,
intravenous vancomycin (1 g twice daily) was commenced
empirically for suspected localised wound infection, with
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otherwise well without features of sepsis. Her serum
potassium levels dropped from4.2mmol/L to 2.9mmol/L
one week after starting vancomycin, and oral potassium
(Sando-K) was promptly initiated and bendroflumethia-
zide stopped. No other changes to her medications had
been made during this time. There was no evidence to
suggest additional potassium loss from the wound or from
the gastrointestinal tract. The patient was subjectively well
with good oral intake. After prolonged recumbency, the
patient developed small bilateral pleural effusions and
peripheral oedema. Administration of low dose oral
furosemide (20 mg) resulted in a significant drop in
serum potassium from 4 mmol/L to 1.7 mmol/L over-
night, which induced pulseless ventricular tachycardia
(VT) prompting cardioversion. Other biochemical para-
meters including sodium (138 mmol/L), corrected cal-
cium (2.4 mmol/L) were normal. She was mildly
hypomagnesaemic (0.5 mmol/L), which was corrected.
Despite aggressive intravenous potassium replacement,
she developed another episode of pulseless VT arrest with
potassium level of 2.8 mmol/L. She was again resuscitated,
with furosemide being converted to spironolactone, a
potassium-sparing diuretic. When stabilised with intrave-
nous potassium supplementation, and then onto 2 Sando
K+ three times daily. Serum investigations performed to
explore the possibility of Cushing’s syndrome and Conn’s
disease were unremarkable. By relating potassium levels
with her medication history, potassium depletion seemed
to correlate with vancomycin therapy, and when com-
bined with furosemide, had led to a dramatic fall in serum
potassium.
Spironolactone was replaced with amiloride to promote
diuresis, which led to mild hyperkalaemia. After finishing
a prolonged course of vancomycin, serum levels had
normalised and amiloride was stopped. Serum potassium
levels remained stable thereafter.
Discussion
Although hypokalaemia following aminoglycoside use is
well recognised [1], this has not previously been reported
inconjunction with vancomycinuse. Severehypokalaemia
has also been reported in conjunction with dicloxacillin
use [2]. Within the British National Formulary [1],
hypokalaemia secondary to vancomycin use is not a
recognised feature. Furthermore, there is no evidence in
the literature to suggest that vancomycin may potentiate
the effects of furosemide.
Three observations could be made from Figure 1:
1) Vancomycin administration per se may have resulted
in the subacute development of hypokalaemia,
2) concomitant use of furosemide and vancomycin may
have resulted in potassium depletion which preceded the
hypokalaemic VF arrests, 3) withdrawal of vancomycin
resulted in the normalisation of serum potassium.
Electrolyte imbalances secondary to loop diuretic use is
well recognised. We appreciate that the use of furosemide
invariably confounds the picture, and some observers
may bring our findings into question. We argue that,
although low doses of oral furosemide may
cause hypokalaemia, it seldom causes hypokalaemia
severe enough to precipitate cardiac arrest, especially if
the patient had tolerated heavier dosages of the drug
previously. There had been no additional losses from her
wound or gastrointestinal tract, and the patient’s food
intake had not been compromised. The patient’s fluctua-
tions in serum potassium had clearly correlated with
vancomycin administration, which had achieved thera-
peutic serum concentrations. We postulate that the
mechanism of vancomycin-induced hypokalaemia, as is
the case with aminoglycoside-induced hypokalaemia, is
through renal wasting. We regret that urinary potassium
had not been measured prior to the window between
vancomycin administration and spironolactone adminis-
tration. We suspect that if this had been done, urinary
potassium concentrations may have been high, thus
reflecting suspected renal losses. A larger study is required
to confirm our findings.
Conclusion
We report a potential case of vancomycin-induced
hypokalaemia which had resulted in cardiac arrest. We
therefore recommend for electrolytes to be monitored in
patients receiving vancomycin therapy, especially those
with concomitant diuretic therapy.
Abbreviation
VT, ventricular tachycardia.
Figure 1. Timeline of events demonstrating fluctuations in
serum potassium in our patient.
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Written consent was obtained from the patient for
publication of this case report and accompanying images.
A copy of the written consent is available for review by
the Editor-in-Chief of this journal.
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